Safety and Efficacy of the Histone Deacetylase Inhibitor Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir (CHARTER)
Phase of Trial: Phase I/II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Tucidinostat (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Acronyms CHARTER
- 10 Jun 2017 Biomarkers information updated
- 04 Sep 2016 Status changed from recruiting to completed.
- 31 Aug 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.